Skip to main content
  • Improvement of median survival time of patients with GBM using multidisciplinary proactive scheduled multiple surgeries approach.

    Final Number:
    1438

    Authors:
    Ali F. Krisht MD; Svetlana Pravdenkova MD, PhD; Sharon Partington RN; Bethany Butler RN

    Study Design:
    Other

    Subject Category:

    Meeting: Congress of Neurological Surgeons 2014 Annual Meeting

    Introduction: The aggressive nature of glioblastoma multiforme shortens median survival inspite of maximal conventional treatments. We evaluated the impact of proactive multiple surgeries approach on the median survival time.

    Methods: Clinical data and outcome of 44 patients treated for primary gioblastoma multiforme (GBM) by senior author (A.F.K.) were retrospectively analyzed using Kaplan-Meier survival curve. 27 patients underwent a proactive multiple surgeries approach for radiologic recurrence irrespective of clinical symptoms resulting in 43 surgeries.

    Results: There were 26 males and 18 females with median age 59 y. Average age 60 (from 29 to 85 y). Average f-up was 17.21 +/- 18.64 mos. Group 1 (17 patients) underwent conventional multidisciplinary treatment including one initial surgery followed by radiation and chemotherapy. Group 2 (27 patients) underwent a more aggressive proactive multiple surgeries based on early signs of radiologic recurrence. Median survival time for group 1 was 14 mos. Group 2 did not reach median survival time during follow up period (p= 0.0011). Mortality rate for group one was – 82% and for group 2 - 39%;

    Conclusions: A strategy of proactive scheduled multiple surgeries approach for GBM based on radiologic occurrence and irrespective of clinical symptomatology results in a significant longer median survival and improvement quality of life.

    Patient Care: Proactive treatment lenghtens survival and quality of life.

    Learning Objectives: 1. To understand the positive impact of aggressive proactive multidisciplinary treatment approach on the median survival time of patient with GBM.

    References: Dolecek TA, Propp JM, Stroup NE, et al: CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. Neuro Oncol 14 Suppl 5:v1-49, 2012

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy